Lester Crawford wins top FDA post
Lester Crawford was confirmed yesterday as the new Commissioner of the US Food and Drug Administration, having already served for more than a year in the post.
Archives for July 18, 2005
Invitrogen looks down under for bovine sera
Invitrogen has opened a bioproduction facility in Australia to make bovine sera products and reagents used in basic research and the production of vaccines and biotherapeutic drugs.
Roche acquires Swiss-based GlycArt
Swiss pharmaceutical firm Roche has acquired GlycArt Biotechnology in an attempt to further strengthen Roche's capabilities in the therapeutic antibody research sector, capitalising on their pre-existing collaboration in September 2004.
Bayer plans to expand Aspirin facility
Bayer has announced an expansion of its Bayer Bitterfeld plant in Saxony Anhalt, Germany, the world's largest production facility for Aspirin.
New company enters pharmacogenomics
The new company has been launched to provide laboratory-based drug discovery and clinical trials services to the pharmaceutical and biotech industries. Lab21 services include lead identification and optimisation, resistance profiling, clinical...
Nasal calcitonin delay hits Upsher-Smith Labs
US pharmaceutical company Upsher-Smith Laboratories has been forced into staffing cuts and a restructuring exercise by delays in the US Food and Drug Administration's review of its nasal calcitonin product for osteoporosis.
Data states IND applications up from 2004
According to latest findings, the biotechnology/pharmaceutical industry submitted 542 commercial Investigational New Drug (IND) applications in 2004, increasing by more than a third from the previous year.
Able Labs files for bankruptcy protection
The trials and tribulations affecting US generics maker Able Laboratories took a decisive turn yesterday when the company filed for Chapter 11 bankruptcy protection, reports Phil Taylor.